Biolase Profit Margin 2006-2018 | BIOL

Current and historical gross margin, operating margin and net profit margin for Biolase (BIOL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Biolase net profit margin as of June 30, 2018 is -40.31%.
Biolase Annual Profit Margins
Biolase Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.027B $0.047B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $63.704B 22.81
McKesson (MCK) United States $26.448B 10.12
Align Technology (ALGN) United States $25.123B 66.98
AmerisourceBergen (ABC) United States $20.078B 14.59
Laboratory Of America Holdings (LH) United States $17.588B 16.18
Cardinal Health (CAH) United States $15.950B 11.08
Henry Schein (HSIC) United States $12.633B 21.54
Cooper (COO) United States $12.492B 22.50
West Pharmaceutical Services (WST) United States $8.366B 43.26
DENTSPLY SIRONA (XRAY) United States $8.067B 14.12
Merit Medical Systems (MMSI) United States $3.433B 45.12
Patterson (PDCO) United States $2.220B 15.60
CONMED (CNMD) United States $2.017B 34.16
STAAR Surgical (STAA) United States $1.782B 238.47
Atrion (ATRI) United States $1.278B 37.87
Antares Pharma (ATRS) United States $0.526B 0.00
Invacare (IVC) United States $0.471B 0.00
Lifevantage (LFVN) United States $0.145B 20.56
Endologix (ELGX) United States $0.134B 0.00
Aceto (ACET) United States $0.066B 43.00
Pro-Dex (PDEX) United States $0.041B 25.70